Allergy Immunization: Not a One-Time Shot — A 3-to-5-Year Course
Allergy immunization (allergen immunotherapy / SCIT) is not a one-time childhood-vaccine-style dose. It's a 3-to-5-year course of escalating allergen extract injections that induces Treg tolerance — not antibody-mediated immunity. Duration: ~39 Year 1 clinic visits (Cox 2011). Post-treatment remission: 4+ years after 3-year grass SCIT (Durham 1999 NEJM).
6 peer-reviewed sources
Allergy immunization = allergen immunotherapy = SCIT. Not a one-time dose. Requires 3–5 years of escalating-dose injections. Mechanism is Treg tolerance induction (not antibody-mediated immunity like MMR/DTaP). WHO 1998 (PMID 9802362) endorsed 'therapeutic vaccines' terminology, but US practice prefers 'immunotherapy' to prevent the one-dose expectation.
Why 'Allergy Immunization' Does Not Mean a One-Time Protective Dose
Patients who type 'allergy immunization' often expect an experience analogous to childhood vaccination: one or two doses, done in a few months, protective for years or decades. Allergen immunotherapy (SCIT) is the opposite of that schedule.
Subcutaneous immunotherapy (SCIT) is a 3-to-5-year course of escalating subcutaneous allergen extract injections per Cox 2011 PP3 (JACI 2011;127[1 Suppl]:S1-S55, DOI 10.1016/j.jaci.2010.09.034). Year 1 alone requires approximately 39 clinic visits — 26–28 weekly build-up injections followed by ~13 early-maintenance visits. Maintenance continues every 2–4 weeks through the end of year 3–5. Patients who stop early rarely achieve the durable remission that completing the full course produces.
The 1998 WHO position paper by Bousquet, Lockey, and Malling (J Allergy Clin Immunol 1998;102[4 Pt 1]:558-562, PMID 9802362) endorsed calling allergen extracts 'therapeutic vaccines for allergic diseases' — which is technically accurate but has caused the one-dose misconception. US specialty practice today prefers 'allergen immunotherapy' specifically to prevent patients from arriving at the allergist expecting a single-visit solution.
Curex pairs at-home IgE testing with allergist review to identify the specific allergens driving symptoms before any immunotherapy course is initiated — the same diagnostic prerequisite described in Cox 2011 PP3.
The closest thing to 'allergy immunization' in outcome terms is the post-treatment durability finding from Durham SR et al (N Engl J Med 1999;341:468-475, DOI 10.1056/NEJM199908123410702): 3 years of SCIT produced 4 additional years of symptomatic remission after treatment was stopped. That durable post-treatment effect is what distinguishes SCIT from symptom-management drugs (antihistamines, nasal steroids, biologics) — but it requires the full multi-year course to achieve.
Allergy immunization = 3-to-5-year SCIT course. Not a one-time shot. Post-treatment remission is possible only after completing the full course. Mechanism is Treg tolerance, not antibody immunity.
Treg Tolerance vs. Antibody Immunity: How Allergy Immunization Differs From Childhood Vaccines
The mechanism by which allergen immunotherapy produces its effects is the immune opposite of the mechanism by which infectious-disease vaccines produce protection.
Antigen (attenuated virus, protein subunit, or mRNA-encoded protein) is presented to naive B cells and T cells. Germinal center reactions produce high-affinity IgG antibodies and long-lived plasma cells. Subsequent pathogen exposure is neutralized by pre-formed antibodies before symptomatic infection develops. One or two doses may be sufficient to establish decades-long memory.
Escalating doses of allergen extract are administered subcutaneously. Repeated sub-symptomatic antigen exposure in the presence of regulatory dendritic cells shifts allergen-specific T cell responses away from Th2 (IL-4, IL-5, IL-13) toward Treg (IL-10, TGF-β). Key outcomes: induction of allergen-specific Treg cells that suppress mast-cell and eosinophil activation; production of IgG4 'blocking' antibodies that compete with IgE for allergen binding; reduction in mast-cell mediator release on re-exposure. This is tolerance induction, not immunity induction. The body learns to not react, rather than learning to destroy a threat.
Treg tolerance is cumulative — it builds with each injection and requires consistent antigen re-exposure to maintain. Unlike antibody memory that persists for decades from a few doses, Treg tolerance erodes without regular dosing (during build-up) and requires 3–5 years of maintenance dosing to become durable post-treatment. Tkacz 2021 (Curr Med Res Opin 2021;37:957-965, DOI 10.1080/03007995.2021.1903848): only 43.9% of 103,207 MarketScan patients reached maintenance, and 23.9% never returned after their first injection — adherence is the single largest predictor of failure.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Allergy Immunization Timeline: Year-by-Year Course
Unlike a childhood vaccine schedule completed in weeks, allergy immunization spans years. Each phase serves a distinct immunological purpose.
1–2 injections per week at escalating allergen concentrations. Begins at 0.05 mL of the most dilute vial. Week-by-week dose escalation allows the immune system to develop tolerance gradually without triggering systemic reactions. ~26–28 visits.
Injection interval extends to every 2 weeks at maintenance concentration. Treg cell populations begin to stabilize. ~13 additional visits in Year 1.
Every 2–4 weeks at maximum tolerated dose. IgG4 blocking antibody levels peak during prolonged maintenance. The biological changes that enable post-treatment remission accumulate over this period.
After completing the full 3-year grass-pollen SCIT course, patients in the Durham 1999 RCT had 4 additional years of symptomatic remission. This is the 'immunization-like' durable effect — but it requires the complete multi-year course to achieve.
Evidence for Allergy Immunization: Cochrane 2007, Durham 1999, PAT 10-Year
Allergen immunotherapy has the largest controlled-trial evidence base of any allergy treatment modality.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youAllergy Immunization vs. Symptom-Management Options
Allergy immunization (SCIT/SLIT) is the only intervention that modifies the underlying disease. All others manage symptoms without producing post-treatment remission.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
SCIT (allergy immunization — injection course) | 3–5 year course | ||||
SLIT tablets (Grastek, Oralair, Ragwitek, Odactra) | 3–5 year daily dosing | ||||
Antihistamines (cetirizine, loratadine, fexofenadine) | Daily as needed indefinitely | ||||
Nasal corticosteroids (fluticasone, budesonide, mometasone) | Daily seasonal or year-round | ||||
Biologics (Xolair, Dupixent, Tezspire) | Ongoing indefinite dosing |
- Efficacy
- Duration
- 3–5 year course
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- 3–5 year daily dosing
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Daily as needed indefinitely
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Daily seasonal or year-round
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Ongoing indefinite dosing
- Cost (5yr)
- Convenience
- Safety
Curex delivers real SCIT allergy shots at home for $129/month — the same multi-year 'allergen immunization' approach, with a personalized serum sterile-compounded to USP <797> standards, prescribed by a board-certified allergist, self-administered as one weekly shot and the first dose plus every dose change supervised live over Zoom with a prescribed epinephrine auto-injector confirmed on hand. Same Treg-induction immunotherapy as clinic SCIT, without the 39-visit Year 1 clinic schedule.
See if at-home shots are right for youFrequently asked questions
Is allergy immunization a one-time shot?
No. Allergy immunization (SCIT) requires approximately 39 clinic visits in Year 1 alone (26–28 weekly build-up injections + ~13 early-maintenance visits) and continues for a total 3-to-5-year course per Cox 2011 PP3. It is not a single-dose schedule like MMR or DTaP.
How is allergy immunization different from an MMR vaccine?
MMR induces antibody-mediated immunity against pathogen-derived antigens in 1–2 doses, with decades-long protection. Allergy immunization induces allergen-specific Treg tolerance via a 3-to-5-year escalating-dose course. The mechanism is the opposite: SCIT teaches the immune system to not react (tolerance), while MMR teaches it to attack a specific pathogen (immunity).
Does allergy immunization provide permanent protection?
Not permanent, but durable. The Durham 1999 NEJM trial showed 3 years of grass-pollen SCIT produced 4 additional years of symptomatic remission post-discontinuation. 'Permanent' is not the right word — but meaningful post-treatment benefit after the full course is established in randomized evidence.
What is the WHO 1998 basis for calling SCIT 'allergen immunization'?
The Bousquet, Lockey, Malling 1998 WHO position paper (JACI 1998;102:558-562, PMID 9802362) endorsed 'therapeutic vaccines for allergic diseases' terminology. US specialty practice shifted to 'allergen immunotherapy' partly to prevent patients from expecting a one-dose vaccination-style schedule.
Can you be allergic to the allergy immunization injection itself?
SCIT injections contain allergen extract — the same substances you are allergic to, delivered in controlled doses. Systemic reactions (generalized hives, asthma, rarely anaphylaxis) occur in ~0.1% of injection visits (Epstein 2013/2014, PMID 24607043). This is why mandatory 30-minute post-injection observation is required per Cox 2011 PP3.
Related Articles
Name of Allergy Shots: SCIT, CPT Codes & Brands | Curex
The clinical name for allergy shots is subcutaneous immunotherapy (SCIT), billed as CPT 95117. There is no branded SCIT product — extracts are custom-mixed from Greer, ALK, or HollisterStier.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreMold Allergy Shots: Evidence & Limits | Curex Guide
Mold SCIT has one well-controlled RCT allergen — Alternaria (Kuna 2011: 63.5% reduction). Cladosporium, Aspergillus, Stachybotrys lack RCT support. Full honest guide.
Read moreAllergy Therapy Shots: SCIT Guide | Curex
Allergy therapy shots = SCIT subset of allergy therapy. 24-28 weekly build-up visits, then 3-5 year maintenance. Cochrane SMD -0.73. SLIT drops are the injection-free alternative.
Read moreBefore and After Allergy Shots | Curex Guide
Meaningful relief from allergy shots arrives at 6-12 months, not 6 weeks. Durham 1999 NEJM shows 7-12 yr durable remission after a 3-yr course — if you finish it.
Read moreAllergy Injection Medication: Complete Category Guide | Curex
Allergy injection medications include SCIT (allergen extract), Xolair, Dupixent, Tezspire, depot steroids, and epinephrine. Only SCIT modifies disease. FDA approval dates and evidence.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.